Patent · US Active

Imidazoquinoline derivatives and their use in therapy

US11274115B2 · kind B2 · utility

0Cited by

2References

23Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Helene Bazin-Lee · Hamilton, US
Jay Evans · Hamilton, US
David Burkhart · Missoula, US
Michael Caramian COCHRAN · Village of La Jolla, US
David A. Johnson · Fayetteville, US

Key dates

Filing date	Sep 5, 2017
Grant date	Mar 15, 2022
Priority date	—
Expiry date	Nov 14, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates inter alia to novel imidazoquinoline derivatives and their use in therapy, particularly as vaccine adjuvants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.